| Net Cash Provided by (Used in) Operating Activities |
-416K |
USD |
+14.8% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q3 2023 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
-87.6K |
USD |
+40.8% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
4.57M |
shares |
+63.8% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.93M |
USD |
+34.5% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
7.51M |
USD |
+6.37% |
Q2 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
7.68M |
USD |
+5.71% |
Q2 2024 |
FY 2024 |
| Depreciation |
6.34K |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
182K |
USD |
0% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
7.2M |
USD |
+14.5% |
Q2 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
44.3M |
USD |
+7.77% |
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
118K |
USD |
-22.4% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
1.07M |
USD |
|
Q2 2024 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
13.9K |
USD |
-77.8% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |